For decades, patient monitoring with oximetry and capnography has been an ASA standard of care. It is linked with our specialty's benchmark improvement in outcomes. Yet even now, these tools remain largely unavailable across low- and middle-income countries. Lifebox was founded in 2011 to address the excess and preventable mortality that results from such gaps. Since its inception, Lifebox has distributed more than 35,000 oximeters – designed to be durable and functional in austere conditions – in 116 countries. Until now, the opportunity to introduce a similarly durable and purpose-fit capnograph has been elusive. The need is clear: a study in Malawi documented a 97% “capnography gap.”
This month will see the launch of the SmileTrain-Lifebox Capnograph – an affordable, high-quality device that meets robust specifications for both the monitoring of pediatric patients and for use in low-resource settings. The device was selected through a rigorous international collaboration, including extensive...
